Abstract
Soft-tissue sarcomas are rare, diverse malignant tumors of mesenchymal origin, requiring diagnosis and treatment by a specialized multidisciplinary team. Initial assessment includes radiology and biopsy, followed by wide surgical resection with clear margins for localized cases. Radiotherapy is recommended for large, deep, high-grade tumors or after incomplete resection, while perioperative chemotherapy may be considered for high-risk cases. In oligometastatic disease, combining local and systemic therapies is an option. Anthracycline-based chemotherapy is the first-line treatment in advanced disease, though other drugs show efficacy in certain subtypes. Given the limited options, enrolling in clinical trials is advised for patients needing further treatment.
Author supplied keywords
Cite
CITATION STYLE
Serrano, C., Arregui, M., Carrasco, I., Hindi, N., Martínez-Trufero, J., Martínez-García, J., … Sala, M. Á. (2025). SEOM-GEIS Spanish clinical guidelines for the management of soft‑tissue sarcomas (2024). Clinical and Translational Oncology, 27(4), 1460–1471. https://doi.org/10.1007/s12094-024-03842-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.